MedTrace Logo

Coronary MDCTA With Iopamidol Injection 370

NCT00558792 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2012-10-24

Study results available
· View outcomes & findings →

Summary

Determine the validity and compare the visualization of arterial segments obtained with 3 doses of iopamidol to determine dose for further investigation in future trials.

Conditions

Interventions

DRUG

Isovue 370, 70 mL

70 mL of iopamidol injection 370 injected at a rate of \>=4 mL/second

DRUG

Isovue 370, 80 mL

80 mL of iopamidol injection 370 injected at a rate of \>=4 mL/second

DRUG

Isovue 370, 90 mL

90 mL of iopamidol injection 370 injected at a rate of \>=4 mL/second

Sponsors & Collaborators

  • Bracco Diagnostics, Inc

    lead INDUSTRY

Principal Investigators

  • Jiefen Yao, M.D. · Bracco Diagnostics, Inc

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00558792 on ClinicalTrials.gov